D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 123 Citations 81,355 475 World Ranking 1376 National Ranking 13

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Cervical cancer

F. Xavier Bosch mainly focuses on Cervical cancer, Internal medicine, Gynecology, HPV infection and Oncology. He studies HPV vaccines, a branch of Cervical cancer. In most of his Internal medicine studies, his work intersects topics such as Immunology.

F. Xavier Bosch has researched Gynecology in several fields, including Dermatology, Cervix and Obstetrics. F. Xavier Bosch focuses mostly in the field of HPV infection, narrowing it down to matters related to Disease and, in some cases, Health care, Anal cancer and Family medicine. His research in Oncology intersects with topics in Cancer, Human Papillomavirus DNA Test, Epidemiology, Linear Array HPV Genotyping Test and Larynx.

His most cited work include:

  • Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer (4869 citations)
  • Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective (3003 citations)
  • Primary liver cancer: Worldwide incidence and trends (1981 citations)

What are the main themes of his work throughout his whole career to date?

F. Xavier Bosch mostly deals with Cervical cancer, Gynecology, Internal medicine, Cancer and Oncology. His study in Cervical cancer is interdisciplinary in nature, drawing from both Human papillomavirus, Epidemiology and Vaccination. His Gynecology research includes themes of Odds ratio, Cervix, Papillomaviridae, Obstetrics and Cervical intraepithelial neoplasia.

The concepts of his Internal medicine study are interwoven with issues in Immunology and Vaccine efficacy. His study explores the link between Cancer and topics such as Risk factor that cross with problems in Case-control study, Carcinoma in situ and Logistic regression. His work carried out in the field of Oncology brings together such families of science as Adenocarcinoma, Attributable risk and Pathology.

He most often published in these fields:

  • Cervical cancer (60.09%)
  • Gynecology (46.48%)
  • Internal medicine (34.74%)

What were the highlights of his more recent work (between 2013-2020)?

  • Cervical cancer (60.09%)
  • Gynecology (46.48%)
  • Vaccination (18.31%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cervical cancer, Gynecology, Vaccination, Internal medicine and Human papillomavirus. Cervical cancer is a subfield of Cancer that he studies. His studies deal with areas such as Cytology and Obstetrics as well as Gynecology.

His Vaccination research incorporates themes from Clinical trial, Environmental health, Young adult, Hpv vaccination and Cervical intraepithelial neoplasia. The study incorporates disciplines such as Genotyping and Oncology in addition to Internal medicine. His Oncology research incorporates elements of Carcinoma and Pathology.

Between 2013 and 2020, his most popular works were:

  • HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis (399 citations)
  • Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis (376 citations)
  • HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients (357 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Disease

The scientist’s investigation covers issues in Internal medicine, Vaccination, Cervical intraepithelial neoplasia, Oncology and Cervical cancer. All of his Internal medicine and Cohort and Risk factor investigations are sub-components of the entire Internal medicine study. His Vaccination research is multidisciplinary, relying on both Young adult and Clinical trial.

The Cervical intraepithelial neoplasia study which covers HPV infection that intersects with Immunology, Vaccine efficacy and Randomized controlled trial. His biological study spans a wide range of topics, including Cancer, HPV vaccines and Pathology. His studies in Cervical cancer integrate themes in fields like Medical record, Gynecology, Time trends and Human papillomavirus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

Nubia Muñoz;F. Xavier Bosch;Silvia de Sanjosé;Rolando Herrero.
The New England Journal of Medicine (2003)

8258 Citations

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

F. Xavier Bosch;M. Michele Manos;Nubia Muñoz;Mark Sherman.
Journal of the National Cancer Institute (1995)

4493 Citations

Primary liver cancer: Worldwide incidence and trends

F.Xavier Bosch;Josepa Ribes;Mireia Díaz;Ramon Cléries.
Gastroenterology (2004)

2955 Citations

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Luisa L. Villa;Gonzalo Perez;Susanne K. Kjaer;Jorma Paavonen.
The New England Journal of Medicine (2007)

2710 Citations

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Silvia de Sanjose;Wim G.V. Quint;Laia Alemany;Daan T. Geraets.
Lancet Oncology (2010)

2167 Citations

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.

Silvia de Sanjosé;Mireia Diaz;Xavier Castellsagué;Gary Clifford.
Lancet Infectious Diseases (2007)

1828 Citations

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud.
The Lancet (2007)

1784 Citations

Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Nubia Muñoz;F. Xavier Bosch;Xavier Castellsagué;Mireia Díaz.
International Journal of Cancer (2004)

1648 Citations

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

Rolando Herrero;Xavier Castellsagué;Michael Pawlita;Jolanta Lissowska.
Journal of the National Cancer Institute (2003)

1542 Citations

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings

Laia Bruni;Mireia Diaz;Mireia Castellsagué;Elena Ferrer.
The Journal of Infectious Diseases (2010)

1455 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing F. Xavier Bosch

Mark Schiffman

Mark Schiffman

National Institutes of Health

Publications: 219

Suzanne M. Garland

Suzanne M. Garland

Royal Women's Hospital

Publications: 190

Chris J.L.M. Meijer

Chris J.L.M. Meijer

Vrije Universiteit Amsterdam

Publications: 190

Silvia Franceschi

Silvia Franceschi

Centro di Riferimento Oncologico

Publications: 187

Joakim Dillner

Joakim Dillner

Karolinska University Hospital

Publications: 183

Eduardo L. Franco

Eduardo L. Franco

McGill University

Publications: 180

Robert D. Burk

Robert D. Burk

Albert Einstein College of Medicine

Publications: 166

Peter J.F. Snijders

Peter J.F. Snijders

Vrije Universiteit Amsterdam

Publications: 164

Rolando Herrero

Rolando Herrero

International Agency For Research On Cancer

Publications: 151

Wim Quint

Wim Quint

Erasmus University Rotterdam

Publications: 149

Luisa L. Villa

Luisa L. Villa

Universidade de São Paulo

Publications: 138

Anna R. Giuliano

Anna R. Giuliano

University of South Florida

Publications: 128

Patti E. Gravitt

Patti E. Gravitt

George Washington University

Publications: 122

Michael Pawlita

Michael Pawlita

German Cancer Research Center

Publications: 120

Allan Hildesheim

Allan Hildesheim

National Institutes of Health

Publications: 116

Susanne K. Kjaer

Susanne K. Kjaer

University of Copenhagen

Publications: 115

Trending Scientists

Stefan B. Williams

Stefan B. Williams

University of Sydney

Xiaopeng ZHANG

Xiaopeng ZHANG

Institute of Automation, Chinese Academy of Sciences

Tarik Taleb

Tarik Taleb

University of Oulu

Ji Hyun Kim

Ji Hyun Kim

Korea University

Maria Valnice Boldrin Zanoni

Maria Valnice Boldrin Zanoni

Sao Paulo State University

Caiting Li

Caiting Li

Hunan University

Ritsert C. Jansen

Ritsert C. Jansen

University of Groningen

Na Lu

Na Lu

China Pharmaceutical University

Sterling J. Nesbitt

Sterling J. Nesbitt

Virginia Tech

Jon J. Major

Jon J. Major

United States Geological Survey

Robert B. Chatfield

Robert B. Chatfield

Ames Research Center

Gerald Seifert

Gerald Seifert

University of Bonn

Stephen J. Till

Stephen J. Till

King's College London

Katherine Luzuriaga

Katherine Luzuriaga

University of Massachusetts Medical School

Leah Friedman

Leah Friedman

Stanford University

Gary E. Gallick

Gary E. Gallick

The University of Texas MD Anderson Cancer Center

Something went wrong. Please try again later.